These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 109206)

  • 21. [Long term results of total skin electron beam therapy (TSEBT) in the treatment of mycosis fungoides].
    Hagedorn M; Hasche E; Kober B; Sander CA
    Hautarzt; 2003 Mar; 54(3):256-64. PubMed ID: 12634995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of treatments for mycosis fungoides and Sézary syndrome: nationwide survey responses.
    Gettler SL; Fung MA
    Dermatol Online J; 2005 Dec; 11(3):6. PubMed ID: 16409902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sezary syndrome variants of cutaneous T-cell lymphoma.
    Whittaker SJ; Foss FM
    Cancer Treat Rev; 2007 Apr; 33(2):146-60. PubMed ID: 17275192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical characteristics and long-term outcome of patients with generalized patch and/or plaque (T2) mycosis fungoides.
    Kim YH; Chow S; Varghese A; Hoppe RT
    Arch Dermatol; 1999 Jan; 135(1):26-32. PubMed ID: 9923777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Whole-skin electron therapy: a therapeutic concept for mycosis fungoides and Sézary syndrome. 2: Therapy].
    Herbst M
    Strahlentherapie; 1984 Mar; 160(3):154-8. PubMed ID: 6729855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Minimal stage IA mycosis fungoides. Results of radiotherapy in 15 patients.
    Piccinno R; Caccialanza M; Percivalle S
    J Dermatolog Treat; 2009; 20(3):165-8. PubMed ID: 18979277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical nitrogen mustard in early mycosis fungoides. A 12-year experience.
    Zachariae H; Thestrup-Pedersen K; Søgaard H
    Acta Derm Venereol; 1985; 65(1):53-8. PubMed ID: 2578706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.
    Kim YH; Liu HL; Mraz-Gernhard S; Varghese A; Hoppe RT
    Arch Dermatol; 2003 Jul; 139(7):857-66. PubMed ID: 12873880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mycosis fungoides. Results of helioclimate therapy in high mountains (Davos, 1,560)].
    Tippel H; Engst R
    Hautarzt; 1986 Aug; 37(8):450-3. PubMed ID: 3759452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Total skin electron therapy of mycosis fungoides and the Sézary syndrome].
    Herbst M; Müller R
    Hautarzt; 1984 Jan; 35(1):16-21. PubMed ID: 6423569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination chemotherapy with bleomycin, cyclophosphamide, prednisone and etretinate (BCPE) in advanced mycosis fungoides: a six-year experience.
    Zachariae H; Thestrup-Pedersen K
    Acta Derm Venereol; 1987; 67(5):433-7. PubMed ID: 2448996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Stanford University experience with conventional-dose, total skin electron-beam therapy in the treatment of generalized patch or plaque (T2) and tumor (T3) mycosis fungoides.
    Navi D; Riaz N; Levin YS; Sullivan NC; Kim YH; Hoppe RT
    Arch Dermatol; 2011 May; 147(5):561-7. PubMed ID: 21576575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechlorethamine desensitization in therapy for mycosis fungoides. Topical desensitization to mechlorethamine (nitrogen mustard) contact hypersensitivity.
    Constantine VS; Fuks ZY; Farber EM
    Arch Dermatol; 1975 Apr; 111(4):484-8. PubMed ID: 1122150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Total cutaneous electron beam therapy of mycosis fungoides].
    Le Bourgeois JP; Levy E; Haddad E; Marinello G; Geara F; Pavlovitch JM
    Ann Dermatol Venereol; 1989; 116(3):213-7. PubMed ID: 2662874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retrospective 5-year review of 131 patients with mycosis fungoides and Sézary syndrome seen at the National Skin Centre, Singapore.
    Tan ES; Tang MB; Tan SH
    Australas J Dermatol; 2006 Nov; 47(4):248-52. PubMed ID: 17034466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Narrowband UVB and PUVA in the treatment of mycosis fungoides: a retrospective study.
    Ahmad K; Rogers S; McNicholas PD; Collins P
    Acta Derm Venereol; 2007; 87(5):413-7. PubMed ID: 17721648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mycosis fungoides and the Sézary syndrome.
    Kim YH; Hoppe RT
    Semin Oncol; 1999 Jun; 26(3):276-89. PubMed ID: 10375085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transfer factor therapy in mycosis fungoides: a double-blind study.
    Thestrup-Pedersen K; Grunnet E; Zachariae H
    Acta Derm Venereol; 1982; 62(1):47-53. PubMed ID: 6175137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The treatment of mycosis fungoides with ointment-based mechlorethamine.
    Price NM; Deneau DG; Hoppe RT
    Arch Dermatol; 1982 Apr; 118(4):234-7. PubMed ID: 7065680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Palliative total skin electron beam therapy (TSEBT) for advanced cutaneous T-cell lymphoma.
    Funk A; Hensley F; Krempien R; Neuhof D; Van Kampen M; Treiber M; Roeder F; Timke C; Herfarth K; Helmbold P; Debus J; Bischof M
    Eur J Dermatol; 2008; 18(3):308-12. PubMed ID: 18474461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.